Planmeca Ultra Low Dose™ Technology Scientifically Proven in Several Studies
Planmeca has earned a reputation as the leader in low dose CBCT imaging. The Planmeca Ultra Low Dose™ protocol has been studied in several studies, one of which concluded that the technology reduces patient doses by up to 77% with no statistical reduction in image quality between the standard and ULD protocols. A recently published … Read more